Target intelligence / Profile preview

VraS histidine kinase (VraS)

Target
VraS
Molecular classification
Enzyme, Histidine kinase, Receptor, Two-component system sensor kinase
01

Overview

VraS histidine kinase is a membrane-bound sensor enzyme functioning as part of the VraSR two-component regulatory system in Staphylococcus aureus and other bacteria[1][2]. The protein detects cell wall stress caused by antibiotics and environmental stimuli, then undergoes histidine autophosphorylation, subsequently transferring the phosphate to the response regulator VraR[1][2]. This phosphorylation cascade activates expression of genes involved in cell wall synthesis, stress adaptation, and resistance to cell wall-active antibiotics including vancomycin and teicoplanin[1][2][5]. Mutations or inhibition of VraS can significantly affect bacterial susceptibility to these antibiotics and have been linked to the emergence of resistant strains (notably VISA—vancomycin-intermediate Staphylococcus aureus)[2][4]. VraS is a validated target for antibacterial drug discovery, and selective inhibitors like NH125 have been shown to sensitize S. aureus to multiple antibiotics by blocking VraS activity[5]. The VraS protein comprises a transmembrane domain, a cytoplasmic kinase (containing the HisKA and HATPase_c domains), and is classified as a type III, unorthodox histidine kinase[1].

Other names
Sensor protein VraSTwo-component system sensor kinase VraSVancomycin resistance-associated sensor protein
02

Mechanism of action

Inhibition of VraS autophosphorylation (e.g., by NH125) Modulation of cell wall stress responses by altering VraS-mediated signal transduction

03

Biological functions

Signal transductionCell wall stress responseAntibiotic resistance regulationActivation of regulatory gene expression
04

Disease associations

InfectionAntibiotic resistance (particularly glycopeptide and vancomycin resistance in Staphylococcus aureus)
05

Safety considerations

Potential for rapid emergence of resistance if VraS signaling is disrupted but not abolished, due to alternative pathwaysInhibition may affect global regulatory networks in bacteria
06

Interacting drugs

NH125

1 more in the full profile.

07

Biomarkers

Upregulation of the vraSR regulon following antibiotic exposure (molecular marker of stress response)

Beyond the preview

Go deeper on VraS histidine kinase (VraS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VraS histidine kinase (VraS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call